Effects of several quinones on insulin aggregation

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Gong, Hao ^a   He, Zihao ^a   Peng, Anlin ^b   Zhang, Xin ^a   Cheng, Biao ^a   Sun, Yue ^c   Zheng, Ling ^c   Huang, Kun ^a,d  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b TONGREN HOSPITAL OF WUHAN UNIVERSITY   (China)

^c WUHAN UNIVERSITY   (China)

^d Wuhan Institute of Biotechnology   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; ANTHRAQUINONE DERIVATIVE; INSULIN; POLYPHENOL; QUINONE DERIVATIVE;

AMYLOIDOSIS; ANIMAL; CHEMISTRY; DRUG EFFECTS; HUMAN; METABOLISM; PIG; PROTEIN AGGREGATION, PATHOLOGICAL; PROTEIN FOLDING; RHEUM;

AMYLOID; AMYLOIDOSIS; ANIMALS; ANTHRAQUINONES; HUMANS; INSULIN; POLYPHENOLS; PROTEIN AGGREGATION, PATHOLOGICAL; PROTEIN FOLDING; QUINONES; RHEUM; SWINE;

EID: 84904168587     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep05648     Document Type: Article

References (63)

1. Cao, P., Abedini, A. & Raleigh, D. P. Aggregation of islet amyloid polypeptide: from physical chemistry to cell biology. Curr Opin Struct Biol 23, 82-9 (2013).
2. Dikiy, I. & Eliezer, D. Folding and misfolding of alpha-synuclein on membranes. Biochim Biophys Acta 1818, 1013-8 (2012).
3. Nussbaum, J. M., Seward, M. E. & Bloom, G. S. Alzheimer disease: a tale of two prions. Prion 7, 14-9 (2013).
4. Lopes, D. H. et al. Mechanism of islet amyloid polypeptide fibrillation at lipid interfaces studied by infrared reflection absorption spectroscopy. Biophys J 93, 3132-41 (2007). (Pubitemid 350097104)
5. Oren, Z. & Shai, Y. Mode of action of linear amphipathic alpha-helical antimicrobial peptides. Biopolymers 47, 451-63 (1998).
6. Mattson, M. P. & Goodman, Y. Different amyloidogenic peptides share a similar mechanism of neurotoxicity involving reactive oxygen species and calcium. Brain Res 676, 219-24 (1995).
7. Naiki, H. & Nagai, Y. Molecular pathogenesis of protein misfolding diseases: pathological molecular environments versus quality control systems against misfolded proteins. J Biochem 146, 751-6 (2009).
8. Yumlu, S., Barany, R., Eriksson, M. & Rocken, C. Localized insulin-derived amyloidosis in patients with diabetes mellitus: a case report. Hum Pathol 40, 1655-1660 (2009).
9. Okamura, S., Hayashino, Y., Kore-Eda, S. & Tsujii, S. Localized Amyloidosis at the Site of Repeated Insulin Injection in a Patient With Type 2 Diabetes. Diabetes Care 36, E200-E200 (2013).
10. Brange, J., Andersen, L., Laursen, E. D., Meyn, G. & Rasmussen, E. Toward understanding insulin fibrillation. J Pharm Sci 86, 517-25 (1997). (Pubitemid 27203397)
11. Huang, K., Dong, J., Phillips, N. B., Carey, P. R. & Weiss, M. A. Proinsulin is refractory to protein fibrillation-Topological protection of a precursor protein from cross-beta assembly. Journal of Biological Chemistry 280, 42345-42355 (2005). (Pubitemid 43023206)
12. Seeliger, J. & Winter, R. Islet amyloid polypeptide: aggregation and fibrillogenesis in vitro and its inhibition. Subcell Biochem 65, 185-209 (2012).
13. Eisele, Y. S. From soluble abeta to progressive abeta aggregation: could prion-like templated misfolding play a role? Brain Pathol 23, 333-41 (2013).
14. Marques, O. & Outeiro, T. F. Alpha-synuclein: from secretion to dysfunction and death. Cell Death Dis 3, e350 (2012).
15. Pan, K. M. et al. Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci USA 90, 10962-6 (1993).
16. Hill, S. E., Miti, T., Richmond, T. & Muschol, M. Spatial Extent of Charge RepulsionRegulates Assembly Pathways for Lysozyme Amyloid Fibrils. PLoS One 6 (2011).
17. Nielsen, L., Frokjaer, S., Brange, J., Uversky, V. N. & Fink, A. L. Probing the mechanism of insulin fibril formation with insulin mutants. Biochemistry 40, 8397-8409 (2001). (Pubitemid 32661900)
18. Nielsen, L., Frokjaer, S., Brange, J., Uversky, V. N. & Fink, A. L. Probing the mechanism of insulin fibril formation with insulin mutants. Biochemistry 40, 8397-409 (2001). (Pubitemid 32661900)
19. Wan, Z. L. et al. Diabetes-associated mutations in human insulin: crystal structure and photo-cross-linking studies of a-chain variant insulin Wakayama. Biochemistry 44, 5000-16 (2005).
20. Kachooei, E. et al. Inhibition study on insulin fibrillation and cytotoxicity by paclitaxel. J Biochem 155, 361-73 (2014).
21. Mishra, N. K., Joshi, K. B. & Verma, S. Inhibition of human and bovine insulin fibril formation by designed peptide conjugates. Mol Pharm 10, 3903-12 (2013).
22. Cheng, B. et al. Inhibiting toxic aggregation of amyloidogenic proteins: a therapeutic strategy for protein misfolding diseases. Biochim Biophys Acta 1830, 4860-71 (2013).
23. Bieschke, J. et al. EGCG remodels mature alpha-synuclein and amyloid-beta fibrils and reduces cellular toxicity. Proc Natl Acad Sci USA 107, 7710-5 (2010).
24. Ono, K., Hasegawa, K., Naiki, H. & Yamada, M. Curcumin has potent anti-amyloidogenic effects for Alzheimer's beta-amyloid fibrils in vitro. J Neurosci Res 75, 742-50 (2004). (Pubitemid 38296087)
25. Mishra, R., Sellin, D., Radovan, D., Gohlke, A. & Winter, R. Inhibiting islet amyloid polypeptide fibril formation by the red wine compound resveratrol. Chembiochem 10, 445-9 (2009).
26. Nie, Q., Du, X. G. & Geng, M.Y. Small molecule inhibitorsofamyloid beta peptide aggregation as a potential therapeutic strategy for Alzheimer's disease. Acta Pharmacol Sin 32, 545-51 (2011).
27. Feng, S., Song, X. H. & Zeng, C. M. Inhibition of amyloid fibrillation of lysozyme by phenolic compounds involves quinoprotein formation. FEBS Lett 586, 3951-5 (2012).
28. Convertino, M., Pellarin, R., Catto, M., Carotti, A. & Caflisch, A. 9, 10-Anthraquinone hinders beta-aggregation: how does a small molecule interfere with Abeta-peptide amyloid fibrillation? Protein Sci 18, 792-800 (2009).
29. Bermejo-Bescos, P. et al. In vitro antiamyloidogenic properties of 1, 4-naphthoquinones. Biochem Biophys Res Commun 400, 169-74 (2010).
30. Misiti, F. et al. Protective effect of rhubarb derivatives on amyloid beta (1-42) peptide-induced apoptosis in IMR-32 cells: a case of nutrigenomic. Brain Res Bull 71, 29-36 (2006). (Pubitemid 44781150)
31. Liu, J. et al. Rhein lysinate decreases the generation of beta-amyloid in the brain tissues of Alzheimer's disease model mice by inhibiting inflammatory response and oxidative stress. J Asian Nat Prod Res 15, 756-63 (2013).
32. Pickhardt, M. et al. Anthraquinones inhibit tau aggregation and dissolve Alzheimer's paired helical filaments in vitro and in cells. J Biol Chem 280, 3628-35 (2005). (Pubitemid 40223830)
33. Siripong, P. et al. Antitumor activity of liposomal naphthoquinone esters isolated from Thai medicinal plant: Rhinacanthus nasutus KURZ. Biol Pharm Bull 29, 2279-83 (2006). (Pubitemid 44690957)
34. Dey, D., Ray, R. & Hazra, B. Antitubercular and Antibacterial Activity of Quinonoid Natural Products Against Multi-Drug Resistant Clinical Isolates. Phytother Res (2013).
35. Kim, J. et al. Pyrroloquinoline quinone inhibits the fibrillation of amyloid proteins. Prion 4, 26-31 (2010).
36. Arora, A., Ha, C. & Park, C. B. Insulin amyloid fibrillation at above 100 degrees C: new insights into protein folding under extreme temperatures. Protein Sci 13, 2429-36 (2004). (Pubitemid 39128863)
37. Dobson, C. M. Protein misfolding, evolution and disease. Trends Biochem Sci 24, 329-32 (1999). (Pubitemid 29421804)
38. Wang, J. B., Wang, Y. M. & Zeng, C. M. Quercetin inhibits amyloid fibrillation of bovine insulin and destabilizes preformed fibrils. Biochem Biophys Res Commun 415, 675-9 (2011).
39. Grudzielanek, S. et al. Cytotoxicity of insulin within its self-assembly and amyloidogenic pathways. J Mol Biol 370, 372-84 (2007). (Pubitemid 46829214)
40. Kelly, J. W. Alternative conformations of amyloidogenic proteins govern their behavior. Curr Opin Struct Biol 6, 11-7 (1996). (Pubitemid 26073939)
41. Gillam, J. E. & MacPhee, C. E. Modelling amyloid fibril formation kinetics: mechanisms of nucleation and growth. J Phys Condens Matter 25, 373101 (2013).
42. Uversky, V. N. Mysterious oligomerization of the amyloidogenic proteins. FEBS J 277, 2940-53 (2010).
43. Ehrnhoefer, D. E. et al. EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers. Nat Struct Mol Biol 15, 558-66 (2008). (Pubitemid 351799141)
44. Zhang, T., Zhang, J., Derreumaux, P. & Mu, Y. Molecular mechanism of the inhibition of EGCG on the Alzheimer Abeta(1-42) dimer. J Phys Chem B 117, 3993-4002 (2013).
45. Brender, J. R. et al. Zinc stabilization of prefibrillar oligomers of human islet amyloid polypeptide. Chem Commun (Camb) 49, 3339-41 (2013).
46. Hyung, S. J. et al. Insights into antiamyloidogenic properties of the green tea extract (-)-epigallocatechin-3-gallate toward metal-associated amyloid-beta species. Proc Natl Acad Sci USA 110, 3743-3748 (2013).
47. Falconi, M. et al. Spectroscopic and molecular dynamics simulation studies of the interaction of insulin with glucose. Int J Biol Macromol 29, 161-8 (2001). (Pubitemid 32895677)
48. Ahmad, E. et al. A mechanistic approach for islet amyloid polypeptide aggregation to develop anti-amyloidogenic agents for type-2 diabetes. Biochimie 93, 793-805 (2011).
49. Wu, C., Lei, H., Wang, Z., Zhang, W. & Duan, Y. Phenol red interacts with the protofibril-like oligomers of an amyloidogenic hexapeptide NFGAIL through both hydrophobic and aromatic contacts. Biophys J 91, 3664-72 (2006). (Pubitemid 44788309)
50. Meyer, E. A., Castellano, R. K. & Diederich, F. Interactions with aromatic rings in chemical and biological recognition. Angew Chem IntEdEngl 42, 1210-50 (2003). (Pubitemid 36410287)
51. Levy-Sakin, M., Shreberk, M., Daniel, Y. & Gazit, E. Targeting insulin amyloid assembly by small aromatic molecules: toward rational design of aggregation inhibitors. Islets 1, 210-5 (2009).
52. DeToma, A. S., Salamekh, S., Ramamoorthy, A. & Lim, M. H. Misfolded proteins in Alzheimer's disease and type II diabetes. Chem Soc Rev 41, 608-21 (2012).
53. Savelieff, M. G., Lee, S., Liu, Y. & Lim, M. H. Untangling amyloid-beta, tau, and metals in Alzheimer's disease. ACS Chem Biol 8, 856-65 (2013).
54. Mancino, A. M., Hindo, S. S., Kochi, A. & Lim, M. H. Effects of clioquinol on metal-triggered amyloid-beta aggregation revisited. Inorg Chem 48, 9596-8 (2009).
55. Hindo, S. S. et al. Small molecule modulators of copper-induced Abeta aggregation. J Am Chem Soc 131, 16663-5 (2009).
56. Gulaboski, R. et al. Hydroxylated derivatives of dimethoxy-1, 4-benzoquinone as redox switchable earth-alkaline metal ligands and radical scavengers. Scientific Reports 3 (2013).
57. Yang, S. G. et al. alpha-Tocopherol quinone inhibits beta-amyloid aggregation and cytotoxicity, disaggregates preformed fibrils and decreases the production of reactive oxygen species, NO and inflammatory cytokines. Neurochem Int 57, 914-22 (2010).
58. Lepoittevin, J. P. & Benezra, C. Allergic contact dermatitis caused by naturally occurring quinones. Pharm Weekbl Sci 13, 119-22 (1991).
59. Zhang, X. et al. Porcine islet amyloid polypeptide fragments are refractory to amyloid formation. FEBS Lett 585, 71-7 (2011).
60. Huang, K., Maiti, N. C., Phillips, N. B., Carey, P. R. & Weiss, M. A. Structure-specific effects of protein topology on cross-beta assembly: studies of insulin fibrillation. Biochemistry 45, 10278-93 (2006). (Pubitemid 44384803)
61. Gong, H. et al. Bisphenol A accelerates toxic amyloid formation of human islet amyloid polypeptide: a possible link between bisphenol A exposure and type 2 diabetes. PLoS One 8, e54198 (2013).
62. Cheng, B. et al. Silibinin inhibits the toxic aggregation of human islet amyloid polypeptide. Biochem Biophys Res Commun 419, 495-9 (2012).
63. Li, Y. et al. Dissecting the role of disulfide bonds on the amyloid formation of insulin. Biochem Biophys Res Commun 423, 373-8 (2012).